Introduction to Epic Research at ORS

Nov 6, 2025 | Conduits News, Edition 8

Epic at Mount Sinai  

Epic is an electronic health record (EHR) system used at Mount Sinai. Epic transforms research workflows into streamlined, scalable, and secure systems.  

Although Sinai has been using Epic for the past decade, in May 2024 One Epic was launched at Mount Sinai Brooklyn (MSB), Mount Sinai Downtown (MSD), and The Mount Sinai Hospital (MSH).  

With this launch, Sinai introduced additional Epic modules such as Radian (Radiology), Bugsy (Infection Control), Transfer Center (Clinical Command Center), and Research, consolidating our clinical systems and streamlining electronic processes across registration, scheduling, radiology, and hospital billing.   

 

Epic Research Team 

The Epic Research Team at ORS provides guidance on how to register research staff for Epic access, submit requests to create and edit Epic study records, recruitment, data reporting, and assistance with the research billing review process.  

If the Epic Research Team is not able to answer a question directly, we are able to put you in contact with someone who can assist further in the Epic research community.  

 

Epic Research Resources 

The Epic Research Team also communicates important research announcements through the listserv. This includes new available features, reporting reminders, and other helpful tips along with tip sheets for future reference.   

Any available Epic Research resources are available either through the CRC Vault, the Research Roadmap, or the Mount Sinai DTP Intranet.  

 

Communicating with the Epic Research Team  

If you need additional guidance, please either submit a Research 411 Ticket or attend weekly virtual Epic Research office hours, which are currently Wednesdays from 1:00-2:00pm.   

A listserv announcement with the Zoom link is sent Wednesday morning. You must have a Mount Sinai email address to gain access.   

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR004419 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required. 

Recent ConduITS News

What is the Mount Sinai Exposomics Core?

The Mount Sinai Exposomics Core centers around The Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai, which was established in 2017 under the leadership of Robert O. Wright, MD, MPH and Rosalind J. Wright, MD, MPH, international leaders...

read more

What does the Exposomics Core do?

The Exposomics Core is at the cutting edge of research to quantify the exposome (i.e., nutrition, social risk factors, and chemical exposure) via lab assays, geospatial modeling, data mining and artificial intelligence. We disseminate our work to cultivate the public...

read more

Highlighted Exposomics Core Events

In 2025, the Exposomics Core was a part of multiple events, including: Lunchtime Chat Webinars (held throughout the year) On January 8, 2025, Maayan Yitshak-Sade, PhD, MPH (Associate Professor, Department of Environmental Medicine, Icahn School of Medicine at Mount...

read more

Exposomics Core Highlighted Information

More information on faculty and staff updates can be found in the departmental newsletters, which are sent out throughout the year. Below are the most recent editions from 2025: December 2025 July 2025 April 2025 The Institute for Exposomic Research is also on...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Dr. Lee 2025 KL2 Scholar

Dr. Lee 2025 KL2 Scholar

Dr. Lee is an Assistant Professor in the Division of Surgical Oncology. Her proposal is titled ‘Generating a Multimodal Machine Learning Model for Prediction of Thyroid Cancer Recurrence’. Her mentors will be: Girish Nadkarni, MD, MPH, Michael Marin, MD, and Gerald...

read more
Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi is an Assistant Professor in the Department of Immunology and Immunotherapy. His proposal is titled ‘Nanoparticle STING Immunotherapy Against TP53-Mutated Acute Myeloid Leukemia’. His mentors will be: Brian Brown, PhD, and Joshua Brody, MD.  Dr. Xiaoqi is...

read more